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Purpose:  We  examine  the  performance  of pure  model-based  iterative  reconstruction  with  reduced-dose
CT in  follow-up  of  patients  with  early-stage  testicular  cancer.
Methods:  Sixteen  patients  (mean  age  35.6  ±  7.4  years)  with  stage  I or II testicular  cancer  underwent  con-
ventional  dose  (CD)  and  low-dose  (LD)  CT  acquisition  during  CT surveillance.  LD  data  was  reconstructed
with  model-based  iterative  reconstruction  (LD–MBIR).  Datasets  were  objectively  and subjectively  ana-
lysed  at  8  anatomical  levels.  Two  blinded  clinical  reads  were  compared  to  gold-standard  assessment  for
diagnostic  accuracy.
Results: Mean  radiation  dose  reduction  of 67.1%  was  recorded.  Mean  dose  measurements  for  LD–MBIR
were:  thorax  – 66 ±  11  mGy  cm  (DLP),  1.0  ±  0.2  mSv  (ED), 2.0  ±  0.4  mGy  (SSDE);  abdominopelvic  –
128  ± 38  mGy  cm  (DLP),  1.9 ± 0.6 mSv  (ED),  3.0  ±  0.6 mGy  (SSDE).  Objective  noise  and  signal-to-noise  ratio
values  were  comparable  between  the  CD and  LD–MBIR  images.  LD–MBIR  images  were  superior  (p  <  0.001)
with  regard  to subjective  noise,  streak  artefact,  2-plane  contrast  resolution,  2-plane  spatial  resolution  and
diagnostic acceptability.  All  patients  were  correctly  categorised  as  positive,  indeterminate  or negative  for
metastatic disease  by 2  readers  on LD–MBIR  and  CD datasets.
Conclusions:  MBIR  facilitated  a 67%  reduction  in  radiation  dose  whilst  producing  images  that  were  com-
parable  or superior  to  conventional  dose  studies  without  loss of diagnostic  utility.
©  2016  The  Authors.  Published  by Elsevier  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND. Introduction
Ionising radiation from medical imaging accounts for sig-
iﬁcantly increasing radiation exposure amongst the general
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population worldwide [1]. The majority of medical imaging radi-
ation comes from computed tomography (CT) procedures, and
patients who  undergo frequent CT examinations may be at
increased risk of radiation-induced malignancies [2]. Radiation
dose-reduction strategies are the subject of ongoing studies.
Testis germ cell tumour (GCTs) are a curable cancer in the major-
ity of patients [3]. The most common site of metastatic spread is
retroperitoneal lymph nodes and CT is the most commonly used
imaging modality for surveillance of patients with early stage dis-
ease after orchidectomy. CT surveillance is standard of care and
critical in identifying recurrent disease, such that it can be treated
with curative intent. Surveillance recommendations vary as to the
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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umber of CT examinations required, and length of follow-up but
he majority of patients require multiple abdominopelvic CTs over
he course of 5–10 follow-up years [4,5].
There is emerging data that patients with stage I seminoma are
t increased risk of second malignancy, in addition to cardiovascu-
ar complications, as a result of adjuvant radiation therapy [6–9]. In
heory, the additional radiation dose from serial CTs could increase
hese risks further, particularly in younger patients. Radiation dose
rom CT surveillance of testicular cancer patients is not insignif-
cant with median lifetime cumulative effective doses (CED) from
25 mSv  [10] to in excess of 200 mSv  [11]. These values are in excess
f median doses received by patient groups with non-neoplastic
hronic diseases that are considered at risk for high lifetime CED
12–15].
Iterative reconstruction is a CT image reconstruction method
hat results in decreased image noise and increased spatial res-
lution. Hybrid iterative reconstruction with low-dose CT has
ndergone considerable research [16–18] and is now being widely
sed. The use of pure, model-based iterative reconstruction (MBIR)
n CT has been recently investigated [19–22] enabling dose reduc-
ions in excess of 65%.
No study has speciﬁcally examined the use of pure iterative
econstruction as a dose reduction technique in follow-up of testic-
lar cancer patients. With this in mind, we designed a prospective
tudy to evaluate the performance of MBIR in low-dose CT assess-
ent of patients undergoing surveillance for stage I or II testicular
ancer.
. Materials and methods
Following ethical approval from the institutional clinical ethics
esearch committee, a prospective HIPAA compliant study design
as utilised. The study was limited to patients with stage I or II
esticular GCT, undergoing surveillance imaging of a previously
iagnosed and staged testicular cancer. The staging used was per
merican Joint Committee on Cancer (AJCC) TNM Staging Systemic
or Testis Cancer (7th ed., 2010). Patients were recruited from medi-
al oncology and radiation oncology services at two  tertiary referral
entres during outpatient clinic visits. Following a detailed discus-
ion, each patient signed an ethics board approved consent form.
xclusion criteria included age <18 years, no previous staging stud-
es, unknown/equivocal histology, ≥stage III disease and patient
efusal.
All patients were scanned using a 128-slice multidetec-
or CT scanner (General Electric Discovery 750HD, GE Medical
ystems, Milwaukee, WI)  using oral and intravenous contrast mate-
ial. A standardised 100 ml  intravenous contrast bolus (Iohexol,
mnipaque 300, GE Healthcare, Mississauga, ON) was deliv-
red at 2.5 ml/s. The referring clinician determined whether CT
horax–abdomen–pelvis or CT abdomen–pelvis were to be per-
ormed. Two  contemporaneous CT scans were acquired, with a 6 s
elay, both imaging identical anatomic areas. The low-dose proto-
ol (LD) was designed in conjunction with the manufacturers using
hantom data to impart a radiation dose of 20–30% of a routine
epartmental CT. The second, conventional dose (CD) protocol was
esigned to impart an ED (effective dose) of 70–80% of a routine CT
can. Thus, patient study participation did not result in increased
adiation dose. LD CT thorax/abdomen–pelvis employed tube volt-
ges of 100 kV/120 kV, rotation times 0.5 s/0.8 s, z-axis automated
ube–current modulation (ATCM) with minimum and maximum
urrent thresholds of 20 and 130 mA/60 and 160 mA,  respec-
ively, and noise indices of 70/41.99. CD CT thorax/abdomen–pelvis
mployed tube voltages of 100 kV/120 kV, rotation times 0.8 s/0.8 s,
-axis ATCM with current thresholds of 50 and 200 mA/120 and
00 mA,  respectively, and noise indices of 34/35.36. Images were Radiology Open 3 (2016) 38–45 39
acquired at 0.625 mm  and reconstructed to 2 mm slices. LD CT data
were reconstructed using a pure iterative reconstruction algorithm
(model-based iterative reconstruction, MBIR, Veo, GE Healthcare,
GE Medical Systems, Milwaukee, WI)  (LD–MBIR). CD CT images
were reconstructed with 60% FBP (ﬁltered back projection) and
40% ASiR (adaptive statistical iterative reconstruction, GE Health-
care) (CD–ASiR) consistent with manufacturer recommendations
and standard departmental CT reconstruction protocol.
2.1. Quantitative analysis of image noise and SNR
LD–MBIR and CD–ASiR images were objectively and subjectively
assessed for image quality. Objective noise was assessed by a sin-
gle reader (KM, 7 years experience). Spherical regions of interest
(ROIs) (diameter, 10 mm;  volume, 519 mm3) were placed in the
following 8 anatomic locations: right supraspinatus muscle at level
of glenoid (level 1), erector spinae at level of carina (level 2), liver
at diaphragm (level 3), liver at porta hepatis (level 4), right renal
cortex at renal hilum (level 5), erector spinae at level of right kid-
ney lower pole (level 6), psoas muscle at iliac crest (level 7) and
gluteus maximus at level of the acetabular roof (level 8). These
measurements were performed using a commercial workstation
(Advantage Workstation VolumeShare 2, Ver4.4, GE Medical Sys-
tems, Milwaukee, WI). At each level, efforts were made to place
the ROI in as homogenous an area as possible, away from blood
vessels etc. Each reconstruction pertaining to a given patient was
simultaneously loaded on the workstation and an ROI was placed
on a dataset, which automatically generated ROIs on the matched
images on the other reconstructions. Mean HU attenuation and HU
ROI standard deviation (SD) were recorded for all datasets. The
latter of these served as an objective measure of noise with signal-
to-noise ratio (SNR) being calculated by dividing mean HU by HU
SD.
Objective noise was  further assessed via a second automated
measurement technique that comprised three steps: edge detec-
tion was performed to detect contours, an iterative algorithm
located homogenous 10 mm ROIs by discounting ROIs which
encompassed any edges/contours highlighted by step one and SDs
of all homogenous ROIs were computed with the lowest four values
being averaged to yield an objective noise measurement. This tech-
nique was  implemented using Matlab® programming language.
2.2. Subjective image quality
Subjective image quality was assessed by 2 readers in consensus
(KM, MM [20 years experience]), using previously validated meth-
ods at the eight levels. Diagnostic acceptability, subjective image
noise and spatial resolution and were scored using a ten-point scale,
and streak artefact was  scored on a three-point scale. Diagnostic
acceptability was  graded as acceptable (score of 5), unacceptable
(score of 1) or excellent (score of 10) respectively, according to
depiction of soft-tissue structures for diagnostic interpretation and
degree of image degradation by artefacts. Subjective image noise
was graded according to the extent of “graininess”/“mottle” present
on CT images and was  graded as acceptable (score of 5) if average
graininess with satisfactory depiction of small anatomic structures
(e.g. blood vessels) and tissue interfaces was seen, unacceptable
(score of 1) if graininess interfered with structure depiction, and
excellent (score of 10) if there was  minimal/no mottle. Regard-
ing contrast resolution, a score of 10 represented superior contrast
depiction between different soft tissues, a score of 1 indicated poor-
est contrast and 5 indicated acceptable contrast. The presence and
impact of streak artefact was  scored at each anatomical level using
a 3-point scheme (0 - no streak artefact; 1 - streak artefact present
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ut not interfering with interpretation; 2 - streak artefact present
nd interfering with interpretation).
.3. Diagnostic accuracy
The presence of ﬁndings on LD–MBIR and CD–ASiR images
as likewise evaluated independently in a blinded fashion by two
ellowship-trained radiology attendings/consultants (AB, KOR) [27
nd 9 years radiology experience, respectively]. To minimise effects
f recall bias, all datasets were anonymised and reviewed in a ran-
om patient order. In addition, a six-week delay was  instituted
etween review of LD–MBIR and CD–ASiR images. Images were
eviewed on 2 mm axial and coronal reformats on soft-tissue, bone
nd lung window settings, using the aforementioned commer-
ial workstation. Readers recorded whether pulmonary nodules,
nlarged mediastinal lymph nodes, abdominal visceral lesions,
bnormal retroperitoneal lymph nodes or osseous abnormalities
ere present or absent, in addition to noting the size of the largest
esion at these sites. Readers documented if CT ﬁndings were
hought to be positive, indeterminate or negative for metastatic
isease. Finally, the presence of incidental ﬁndings was acknowl-
dged. A similar but un-blinded ‘gold-standard’ clinical read, where
rior studies and all clinical details were available, was  performed
y 2 radiologists in consensus (KM, MM).  Subsequent follow-up
maging was monitored for metastatic disease.
.4. Radiation dose
Regarding radiation dose parameters, dose length product (DLP)
as recorded for each examination. Estimated Dose (ED) (utilising
CRP 103 [23] compliant CT patient dosimetry calculator (ImPACT,
ondon, England)) and size-speciﬁc dose estimates (SSDE) (per
merican Association of Physicists in Medicine (AAPM)) guidelines
24,25] for each study were also calculated.
Patient height, weight and body mass index (BMI) at the time of
T were recorded.
All statistical tests were performed with Statistical Package for
ocial Sciences (SPSS) version 21.0 (IBM, Armonk, NY). Wilcoxon
igned rank test was used for statistical analysis to compare quali-
ative parameters. Normally distributed quantitative indices were
ompared using paired t-test. A p-value of <0.05 was considered
tatistically signiﬁcant. All data are presented as mean ± standard
eviation (SD) unless otherwise stated.
. Results
Sixteen patients with a mean age of 35.6 ± 7.4years (range
4–47years) participated. All patients referred for inclu-
ion agreed to participate. Mean BMI  was 26.7 ± 3.9 kg/m2
range 20.7–32.9 kg/m2). 11 patients underwent CT
horax–abdomen–pelvis and 5 underwent abdominopelvic CT
lone. The following histological subtypes were recorded: semi-
oma (8 patients), non-seminomatous GCT (5 patients) and mixed
ype (3 patients). 15 of the patients had stage I disease at diagnosis
nd 1 patient had stage II disease with prior retroperitoneal lymph
ode dissection.
.1. Radiation dose
CD–ASiR thoracic CTs had the following mean radiation
ose parameters: 197 ± 52 mGy  cm (DLP), 3.2 ± 0.8 mSv  (ED),
.8 ± 1.4 mGy  (SSDE). LD–MBIR thoracic studies mean radia-
ion factors were 66 ± 11mGy cm (DLP), 1.0 ± 0.2 mSv  (ED) and
.0 ± 0.4 mGy  (SSDE).
Regarding abdominopelvic CTs, CD–ASiR mean radiation
oses were 395 ± 95 mGy  cm (DLP), 5.9 ± 1.4 mSv  (ED) and Radiology Open 3 (2016) 38–45
9.3 ± 1.6 mGy  (SSDE). Mean LD–MBIR abdominopelvic CT doses
were 128 ± 38 mGy  cm (DLP), 1.9 ± 0.6 mSv  (ED) and 3.0 ± 0.6 mGy
(SSDE). A mean dose reduction of 67.1 ± 4.0% was  recorded between
LD–MBIR and CD–ASiR studies (using DLP measurements). Using
the summated dose of both LD and CD studies that each patient
received as a measure of what the patient would receive if
not included in this study and had undergone standard depart-
mental protocol, LD–MBIR studies achieved a mean reduction of
75.3 ± 2.3%.
3.2. Quantitative analysis of image noise and SNR
Objective image noise and SNR were evaluated at the 8 levels
described above. Fig. 1 demonstrates mean and SD of mean noise
measurements for CD–ASiR and LD–MBIR images. There was no
signiﬁcant difference between datasets at any of the 8 levels (p-
values: 0.132–0.814). When mean objective noise measurements
for all levels were compared for datasets, LD-MBIR noise lev-
els (27.55 ± 8.12) were insigniﬁcantly lower than CD–ASiR values
(27.68 ± 9.01; p = 0.873).
Results of objective SNR are displayed in Fig. 2. There was no sig-
niﬁcant difference between CD–ASiR and LD–MBIR images at any
of the 8 levels (p-values: 0.201–0.897). For all level SNR calcula-
tions, LD–MBIR values (3.62 ± 1.99) were insigniﬁcantly superior
to CD–ASiR calculations (3.53 ± 2.02; p = 0.510).
Regarding the second objective noise method, despite produc-
ing lower SD values than the previous objective assessment, there
was again no signiﬁcant difference between datasets at any of
the 8 levels. However, when mean objective noise measurements
for all levels were compared for the datasets, LD–MBIR noise lev-
els (23.28 ± 6.77) were insigniﬁcantly higher than CD–ASiR values
(23.11 ± 7.44; p = 0.859).
3.3. Subjective image quality
No signiﬁcant difference was  found across 8 anatomical levels
for each subjective parameter, hence mean values for all lev-
els were summated to compare LD–MBIR and CD–ASiR quality.
LD–MBIR scores were signiﬁcantly superior (p < 0.001 for all com-
parisons) to CD–ASiR values in terms of subjective noise (9 ± 0
[median ± interquartile range] vs. 7 ± 0), streak artefact (0 ± 0 vs.
1 ± 0), axial contrast resolution (9 ± 0 vs. 7 ± 1), axial spatial reso-
lution (9 ± 1 vs. 8 ± 0), coronal contrast resolution (9 ± 1 vs. 8 ± 0),
coronal spatial resolution (9 ± 1 vs. 8 ± 0), axial diagnostic accept-
ability (9 ± 1 vs. 8 ± 1) and coronal diagnostic acceptability (9 ± 0
vs. 8 ± 1) (Fig. 3).
3.4. Diagnostic accuracy
Of the 16 patients in the study, none had conﬁrmed metastatic
disease on study imaging or on subsequent follow-up (mean
follow-up 19.13 ± 5.0 months). Thirteen had no ﬁndings, per ‘gold-
standard’ analysis, that were concerning for metastatic recurrence.
Three of 16 patients had indeterminate ﬁndings for metastatic
disease. Of these, 2 patients had retroperitoneal lymph nodes of
10–11 mm in short axis diameter (Figs. 4 and 5 ) and 1 patient
had multiple small non-calciﬁed pulmonary nodules (Fig. 6). Both
reader 1 and reader 2 accurately stratiﬁed all 16 patients as being
indeterminate or negative for metastatic disease, where applicable,
on both CD–ASiR and LD–MBIR images, hence showing complete
‘gold-standard’ correlation.
Reader 1 recorded the same 17 incidental ﬁndings on both
CD–ASiR and LD–MBIR studies. Reader 2 documented 17 inciden-
tal ﬁndings on LD–MBIR studies and 15 on CD–ASiR images. These
included calciﬁed pulmonary granulomata, aberrant right subcla-
vian artery, hepatic cysts (Figs. 7 and 8), renal scarring, benign
K.P. Murphy et al. / European Journal of Radiology Open 3 (2016) 38–45 41
Fig 1. Objective image noise assessment at the 8 assessed levels: right supraspinatus muscle at the level of the glenoid (level 1), erector spinae at the level of the carina (level
2),  liver at diaphragm (level 3), liver at porta hepatis (level 4), right renal cortex at the renal hilum (level 5), erector spinae at level of the right kidney lower pole (level 6),
psoas  muscle at the iliac crest (level 7) and gluteus maximus at the level of the acetabular roof (level 8).
Fig. 2. Objective signal-to-noise ratio (SNR) at the 8 assessed levels.
s were
o
e
ﬁ
n
wFig. 3. Subjective image quality analysis. LD–MBIR image
sseous sclerosis/bone islands and degenerative vertebral dis-
ase. The ‘gold-standard’ analysis identiﬁed 24 potential incidental
ndings. Of these, only 2 were deemed as ‘likely to be clinically sig-
iﬁcant’ according to ACR RadPeer scoring system [26]. One of these
as enlargement of the thymic remnant, which was identiﬁed by signiﬁcantly superior (p < 0.001) for all recorded factors.
both blinded readers on LD–MBIR and CD–ASiR images. The sec-
ond was a 24 mm lesion abutting the gallbladder that was isodense
to adjacent liver, and was  identiﬁed by reader 2 on the CD–ASiR
images. Reader 2 did not identify the lesion on LD–MBIR images and
reader 1 did not pinpoint it on either LD–MBIR or CD–ASiR recon-
42 K.P. Murphy et al. / European Journal of Radiology Open 3 (2016) 38–45
Fig. 4. Coronal CT images of the abdomen in a 36-year-old patient (BMI 20.7 kg/m2) who underwent low-dose CT of the abdomen–pelvis (B) with estimated effective dose
of  0.97 mSv  (ED). Mildly enlarged retroperitoneal nodes (arrows) are clearly seen on both CD–ASiR (A) and LD–MBIR (B) images.
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(ig. 5. Axial CT images of the abdomen in a 47-year-old patient (BMI 28.6 kg/m2) w
tudy (B). A mildly enlarged lymph node anterior to the abdominal aorta (arrows) i
tructions. This abnormality, with the beneﬁt of prior studies and
ull clinical information, was deemed to be a haematoma from prior
urgery and was graded as ‘2b’ (‘discrepancy in interpretation/not
rdinarily expected to be made’) per RadPeer [26].
. Discussion
Patients with testicular cancer, particularly those with stage
–II disease, have an excellent prognosis, tend to be young and
re potentially at risk of high lifetime CED, given the intense CT
urveillance strategies recommended by international guidelines.
ultiple clinical series, of over 1200 patients, with early stage semi-
oma managed by post-orchidectomy surveillance, have reported
ecurrence rates of 15–20% and nearly all of these patients are cured
ith either chemotherapy or radiotherapy. Regular surveillance is
herefore critical. Exposure to high doses of ionising radiation can
otentially lead to organ dysfunction and malignancy. In a patient
roup with a curable malignancy, this is especially relevant. Hence,
his patient group are an ideal cohort to consider for reduced dose
T scanning as part of clinical surveillance for metastatic disease.
In our study, mean ED of 1.05 ± 0.17 mSv  (65.65 ± 10.7 mGy  cm
DLP)) and 1.92 ± 0.57 mSv  (128.02 ± 38.3 mGy  cm (DLP)) for low- estimated effective dose (ED) of 3.1 mSv  for the low-dose thorax–abdomen–pelvis
ent on both CD–ASiR (A) and LD–MBIR (B) studies.
dose thoracic and abdominopelvic CT examinations, respectively,
were achieved. These values were obtained at a 67% mean reduction
when compared with the CD studies and a 75% average reduc-
tion when compared with an estimated standard departmental
protocol. Despite this dose reduction, LD–MBIR image quality was
comparable to CD–ASiR studies with regard to objective image
quality analysis and superior in terms of subjective quality assess-
ment. Blinded image interpretation showed complete agreement
in identifying patients with ﬁndings negative or indeterminate for
metastatic disease when compared with un-blinded gold-standard
assessment.
Radiation dose measurements are considerably superior to prior
investigations of low-dose testicular cancer CT imaging [27,28].
O’Malley et al. achieved a mean low-dose abdominopelvic CT DLP
of 452 mGy  cm,  which is ∼3.5 times greater than the mean ED
achieved in our study. Gnannt et al. achieved a mean DLP of
636.9 mGy cm for low-dose abdominopelvic CT with ATCM, which
is substantially higher than in our study. Prior publications on low-
dose CT use in other oncology patient groups, such as lymphoma
patients, have achieved dose reductions of approximately 50% [29].
Our current study represents a more substantial dose reduction in
a similar patient group.
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Fig. 6. Axial CT images of the chest in a 36-year-old patient (BMI 21.0 kg/m2) with an estimated effective dose of 1.86 mSv  ED for the low-dose thorax–abdomen–pelvis study
(B).  Subcentimetre pulmonary nodules (arrows) are clearly visible on both CD–ASiR (A) and LD–MBIR (B) datasets.
Fig. 7. Axial CT images from a 46-year-old study participant (BMI 31.3 kg/m2) that had a low-dose abdominopelvic CT performed for an ED of 2.64 mSv (B). Small hepatic
cysts  are visible on both CD–ASiR (A) and LD–MBIR (B) images.
44 K.P. Murphy et al. / European Journal of Radiology Open 3 (2016) 38–45
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[Fig. 8. Zoomed up axial CT images from the patient in Fig. 
MRI  is being investigated as an alternative to CT in follow-up
f these patients but CT remains the gold-standard method. MRI,
hen read by experienced radiologists, reportedly yields compara-
le results to CT in assessing the retroperitoneum in patients with
esticular GCT [30]. A large on-going trial is investigating the use of
RI  in stage I seminoma [TRISST Trial, Medical Research Council,
K; ClinicalTrials.gov identiﬁer NCT00589537].
Reduced dose CT is a desirable alternative to conventional dose
T. Multiple strategies are available to reduce CT radiation dose
 these include technical factors at the time of the study [28] in
ddition to alterations in frequency of surveillance [31]. Our results
uggest that pure iterative reconstruction is a valuable additional
echnical CT dose reduction strategy.
A number of study limitations can be identiﬁed. It was consid-
red unethical to subject patients to two studies that would have
esulted in their receiving a total overall radiation dose in excess
f our usual departmental protocol. Therefore, the total dose used
n both CD and LD protocols was set at that which would have
een received under normal protocols, with CD protocol utilised
or this study conferring 70–80% of standard departmental pro-
ocol dose. Thus, CD images used for LD image comparison do
ot represent what would have been produced during conven-
ional departmental scanning, but rather are derived from a dose
lightly lower than usual. Nonetheless, it seems valid to use this
lightly reduced dose dataset as a conventional dose benchmark,
iven that the study purpose was to conﬁrm no loss of diagnos-
ic capability with further, greater, dose reduction. Secondly, the
adiation dose from the scanned projection radiograph (topogram)
as excluded from dose calculation, per EU rules for assessing
T radiation dose, hence the dose per study was slightly under-
stimated. Thirdly, reviewer blinding as to the scanning protocol
uring clinical interpretation was not fully possible as LD–MBIR
mages had an obviously different appearance to CD–ASiR images.
o reduce recall bias, randomised LD–MBIR datasets were read
ix weeks prior to randomised CD–ASiR dataset assessment. Iter-
tive reconstruction algorithms from only a single vendor (GE
ealthcare) were assessed. It must also be stated that a signiﬁ-
ant drawback of MBIR is the relatively long reconstruction time
equired (20–45 min  per dataset at present) compared with near
nstantaneous hybrid IR. In the setting of outpatient CT scanning for
esticular cancer surveillance, however, immediate image recon-
truction is not required. Finally, these results are only directly
pplicable to follow-up of patients with testicular cancer though
t is not unreasonable to surmise that it is an acceptable strategy
or other patient cohorts.
In conclusion, our results show that reduced dose CT imag-
ng, with pure model-based iterative reconstruction, may  be an
mportant tool in the future surveillance of testicular cancer
atients.
[s CD–ASiR (A) and LD–MBIR (B) images of the liver cysts.
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